Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women

American Journal of Cardiology

Volumn 82, Issue 2, 1998, Pages 256-258

  English, JoAnna L ^b   Jacobs, Laura O ^b   Green, Garfield G ^b   Andrews, Thomas C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; ARTERY COMPLIANCE; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; ESTROGEN BLOOD LEVEL; ESTROGEN RELEASE; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE RELEASE; VASCULAR ENDOTHELIUM;

EID: 0032528219     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00322-1     Document Type: Article

References (19)

1. 1. Lieberman E, Gerhard M, Uehata A, Walsh B, Selwyn A, Ganz P, Yeung A, Creager M. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-941.
2. 2. Gilligan D, Badar D, Panza J, Quyyumi A, Cannon R. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786-791.
3. 3. Gilligan D, Quyyumi A, Cannon R. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89:2545-2551.
4. 4. Williams J, Adams M, Herington D, Clarkson T. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-457.
5. 5. Negre-Salvayre A, Pieraggi M, Mabile L, Salvayre R. Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993;99:207-217.
6. 6. Akishita M, Ouchi Y, Miyoshi H, Kozaki K, Inoue S, Ishikawa M, Eto M, Toba K, Orimo H. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 1997;130:1-10.
7. 7. Caulin-Glaser T, Watson C, Pardi R, Bender J. Effects of 17 beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996;98:36-42.
8. 8. Nakai K, Itoh C, Hotta K, Itoh T, Yoshizumi M, Hiramori K. Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 beta in human umbilical vein endothelial cells. Life Sci 1994;54:PL221-227.
9. 9. Levine R, Chen S, Durand J, Chen Y, Oparil S. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation 1996;94:2221-2227.
10. 10. Hashimoto M, AKishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Sagara Y, Taketani Y, Orimo H, Ouchi Y. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995;92:3431-3435.
11. 11. Miller V, Vanhoutte P. Progesterone and modulation of endothelium-dependent response in canine coronary arteries. Am J Physiol 1991;261:R1022-R1027.
12. 12. Andrews T, Whitney E, Green G, Kalenian R, Personius B. Effect of gemfibrozil ± niacin ± cholestryramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high density lipoprotein cholesterol levels <40 mg/dl. Am J Cardiol 1997;80:831-835.
13. 13. Joannides R, Haefeli W, Linder L, Richard V, Bakkali E, Thuillez C, Luscher T. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-1319.
14. 14. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995;214:847-855.
15. 15. Hayashi T, Fukuto J, Ignarro L, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 1992;89:11259-11263.
16. 16. Miyagawa K, Rosch J, Sanczyk F, Hermsmeyer K. Medroxyprogesterone interferes with ovarian steoid protection against coronary vasospasm. Nature Med 1997;3:324-327.
17. 17. McCrohon J, Adams M, McCredie R, Robinson J, Pike A, Abbey M, Keech A, Celermajer D. Hormone replacement therapy is associated with imporved arterial physiology in healthy post-menopausal women. Clin Endocrinol 1996; 45:435-441.
18. 18. Kharitonov S, Logan-Sinclair R, Busset C, Shinebourne E. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J 1994;72:243-245.
19. 19. Chester A, Jiang C, Borland J, Yacoub M, Collines P. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron Artery Dis 1995;6:417-422.